Tempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 10,000 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the sale, the chief executive officer owned 201,047 shares of the company’s stock, valued at approximately $12,062,820. This represents a 4.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The stock was sold at an average price of $44.07, for a total value of $597,148.50.

Tempus AI Stock Down 4.7%

NASDAQ TEM traded down $2.82 during mid-day trading on Wednesday, hitting $57.27. The company’s stock had a trading volume of 4,732,815 shares, compared to its average volume of 5,979,971. The firm has a market capitalization of $10.28 billion, a price-to-earnings ratio of -33.30 and a beta of 3.46. The company’s 50 day simple moving average is $50.82 and its 200 day simple moving average is $54.38. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96. Tempus AI, Inc. has a twelve month low of $41.73 and a twelve month high of $104.32.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The firm had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. During the same quarter in the prior year, the company posted ($0.24) earnings per share. The business’s revenue was up 36.1% on a year-over-year basis. Analysts anticipate that Tempus AI, Inc. will post -1.35 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on TEM. Wolfe Research initiated coverage on Tempus AI in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. BTIG Research reissued a “buy” rating and issued a $80.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Jefferies Financial Group initiated coverage on Tempus AI in a report on Monday, April 13th. They issued an “underperform” rating and a $35.00 target price on the stock. Freedom Capital upgraded Tempus AI to a “hold” rating in a report on Tuesday, June 30th. Finally, Wall Street Zen lowered Tempus AI from a “hold” rating to a “sell” rating in a research report on Saturday. Nine research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $68.54.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Victory Capital Management Inc. increased its position in shares of Tempus AI by 1.5% during the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock valued at $894,000 after acquiring an additional 162 shares during the last quarter. US Bancorp DE boosted its position in Tempus AI by 6.6% in the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock worth $230,000 after purchasing an additional 176 shares during the last quarter. Legacy Bridge LLC boosted its position in Tempus AI by 1.6% in the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock worth $733,000 after purchasing an additional 193 shares during the last quarter. Truist Financial Corp grew its stake in Tempus AI by 5.8% in the 4th quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock valued at $209,000 after purchasing an additional 194 shares during the period. Finally, Farther Finance Advisors LLC increased its position in shares of Tempus AI by 3.5% during the 4th quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock valued at $377,000 after purchasing an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.